Scientists argue heart stem cell trial should be paused

Scientists argue heart stem cell trial should be paused

Days after Harvard Medical School said it found extensive falsified or fabricated data from the laboratory of a prominent heart researcher, doctors and scientists are urging a halt to a medical trial based in part on his work. They say that sick people should not be subjected to the risks of an experiment whose underlying […]

Breast cancer vaccine in clinical trials

Breast cancer vaccine in clinical trials

INDIANAPOLIS (WTHR) — The Mayo Clinic in Jacksonville, Florida, is working on a vaccine for triple negative breast cancer that could save millions if successful, WFLA reported. Triple negative breast cancer is a type of cancer not supported by hormonal therapy or therapies that target HER2 receptors, according to breastcancer.org. But other medicines can be […]

Partnership aims to bring early-phase trials to more patients

Partnership aims to bring early-phase trials to more patients

Marc Matrana PHOENIX —A partnership between Ochsner Health System and Translational Genomics Research Institute, or TGen, brought phase 1 and phase 2 clinical trials to patients across Louisiana who may not have had access otherwise, according to a presentation at the Association of Community Cancer Centers National Oncology Conference. “Clinical trials are critically important for […]

Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal …

Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal …

Combines Neon’s Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic Non-Small Cell Lung Cancer Trial SAN CARLOS, Calif. and CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and Neon Therapeutics, Inc. (NASDAQ: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, […]

To recruit for clinical trials, throw out the usual ad playbook: study

To recruit for clinical trials, throw out the usual ad playbook: study

The difficulty of recruiting volunteers for clinical trials gets a lot of attention these days. A lesser appreciated aspect of drug development, perhaps, is the burden on patients, especially how much is required to participate in research. “[Clinical trials are] a commitment of time, of yourself, of travel, and of money,” said Matthew Snodgrass, digital […]

United Neuroscience to Present Alzheimer's Vaccine Clinical Trial Update at CTAD 2018

DUBLIN, Oct. 18, 2018 /PRNewswire/ — United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brain disorders, today announced that the company will present a clinical trial update for its lead vaccine candidate, UB-311, at the International Conference on Clinical Trials for Alzheimer’s Disease (CTAD), which takes place […]

Re: Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of …

Re: Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of …

Re: Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors | The BMJ We use cookies to improve our service and to tailor our content and advertising to you. More info Close You can manage your cookie settings via your browser at any time. To […]

Rodin Therapeutics Launches Clinical Trial of Neuroimaging Tool for Measurement of Synaptic Density

Rodin Therapeutics Launches Clinical Trial of Neuroimaging Tool for Measurement of Synaptic Density

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Rodin Therapeutics today announced the launch of a clinical trial to assess the performance of a new PET ligand that can measure synaptic density in the living brain. Insights from the study will guide Rodin’s upcoming Phase 1b trial of a novel therapeutic compound designed to strengthen and increase the number of synapses […]

GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of …

GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of …

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris: SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported additional results at Week 72 from the REVERSE Phase III clinical trial, which evaluates the safety and efficacy of a single […]